Literature DB >> 9154204

Use of carprofen for the treatment of pain and inflammation in dogs.

S M Fox1, S A Johnston.   

Abstract

Most studies of nonsteroidal anti-inflammatory drugs (NSAID) do not demonstrate appreciable differences in efficacy. As awareness of the adverse effects associated with NSAID use increases, safety is becoming the primary concern among physicians when selecting NSAID for use by their human patients. However, veterinarians may be less aware of the safety concerns associated with NSAID use. A wide range of NSAID is used to treat human beings with osteoarthrits; however, it is imperative to remember that dogs are especially sensitive to these drugs, and reports of serious, and occasionally fatal, complications are numerous. Carprofen is a propionic acid-derived NSAID that has anti-inflammatory, analgesic, and antipyretic activity. In animals, carprofen is as potent as indomethacina and more potent than aspirin or phenlbutazone, but carprofen appears to be safer than most other NSAID.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154204

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Carprofen-induced oxidative stress in mitochondria of the colonic mucosa of the dog.

Authors:  Lynne A Snow; Rebecca S McConnico; Timothy W Morgan; Erica Hartmann; Jacqueline R Davidson; Giselle Hosgood
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

2.  A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

Authors:  Laura Bertolacci; Elisa Romeo; Marina Veronesi; Paola Magotti; Clara Albani; Mauro Dionisi; Chiara Lambruschini; Rita Scarpelli; Andrea Cavalli; Marco De Vivo; Daniele Piomelli; Gianpiero Garau
Journal:  J Am Chem Soc       Date:  2012-12-21       Impact factor: 15.419

3.  Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay.

Authors:  Juan D Guzman; Dimitrios Evangelopoulos; Antima Gupta; Kristian Birchall; Solomon Mwaigwisya; Barbara Saxty; Timothy D McHugh; Simon Gibbons; John Malkinson; Sanjib Bhakta
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

4.  Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.

Authors:  Liang-Hui Chu; Brian H Annex; Aleksander S Popel
Journal:  Front Pharmacol       Date:  2015-08-25       Impact factor: 5.810

5.  Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus).

Authors:  Anna Hielm-Björkman; Riitta-Mari Tulamo; Hanna Salonen; Marja Raekallio
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.